Dear Journalism, this is embarassing
Ask tough q:
Here are 4
1. If someone gets a 3rd dose, what do they gain-- a reduction in mild disease, severe disease-- and what data supports your view? Will it be made public?
Conversation
Replying to
2. Why would the industry not push for an annual or bi-annual shot if the burden to debut a 3rd dose is not RCT measuring clinical endpoints?
3
31
382
3. What is the rate of myocarditis with the 3rd dose-- particularly in men 16-24 -- how do you know this?
3
46
526
3. What data supports the claim: mandating of masks will lower spread of sars-cov-2 in schools?
Why not run a proper trial, given the issue is divisive?
What do you say to the United Kingdom, which never masked <12 even during delta wave?
15
91
695
4. Among the unvaccinated 80 million people, how many have ALREADY recovered from prior infection?
How do you track this? How does this affect your thinking?
29
73
715
Does the booster dose use the EUA drug or the drug that was fully approved?
4
1
9
It's the same thing, right? Pfizer got full approval following EUA, Moderna still on EUA. The boosters aren't specific to delta or other variants.
2
1
Show replies
Replying to
Another question, why are we using the same vaccine that was developed for the alpha variant when the Delta variant is the current majority of infections.
1
Show replies
Did they change anything or is the Booster just the same cocktail as before? Since they are trying to blame variants...
2
2
16